VYNE icon

VYNE Therapeutics
VYNE

Overview Fund Trends Analyst Outlook Journalist POV

44 hedge funds and large institutions have $5.63M invested in VYNE Therapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

59% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 17

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
44
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$88K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$91K
2
+$77.4K
3
+$49K
4
Mackenzie Financial
Mackenzie Financial
Ontario, Canada
+$42K
5
Renaissance Technologies
Renaissance Technologies
New York
+$39.4K

Top Sellers

1
-$2.22M
2
-$498K
3
-$222K
4
Marshall Wace
Marshall Wace
United Kingdom
-$169K
5
Goldman Sachs
Goldman Sachs
New York
-$118K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$12K
27
$10K
28
$8K
29
$7K
30
$7K
31
$5K
32
$3K
33
$2K
34
$1K
35
$1K
36
$1K
37
$1K
38
$1K
39
$1K
40
$1K
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3